EP Patent

EP0389995A2 — Isoquinoline derivatives for the treatment of glaucoma or ocular hypertension

Assigned to Nisshin Seifun Group Inc · Expires 1990-10-03 · 36y expired

What this patent protects

The use of isoquinoline derivatives for the treatment of glaucoma or ocular hypertension. The isoquinoline derivatives are of formula I <CHEM> wherein R1 is a hydrogen atom or a C1-C6 alkyl group and R2 is a C1-C6 alkyl group. The stability of the isoquinoline derivatives w…

USPTO Abstract

The use of isoquinoline derivatives for the treatment of glaucoma or ocular hypertension. The isoquinoline derivatives are of formula I <CHEM> wherein R1 is a hydrogen atom or a C1-C6 alkyl group and R2 is a C1-C6 alkyl group. The stability of the isoquinoline derivatives when used in the form of a solution is improved by incorporating therein compounds having a phenolic hydroxyl group and/or glycols serving as a stabilizer.

Drugs covered by this patent

Patent Metadata

Patent number
EP0389995A2
Jurisdiction
EP
Classification
—
Expires
1990-10-03
Drug substance claim
No
Drug product claim
No
Assignee
Nisshin Seifun Group Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.